CTO NEXUS LATAM LLC – Trademark Portfolio

Entity Type: 16

CTO NEXUS LATAM LLC holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 2 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 2 Nice Classification classes. Currently, 1 trademark is registered and 1 is pending. Notable registered marks include MYPAGE. The owner is based in Carolina, PR.

5890 Calle Tartak, #204-A

Carolina, PR 00979

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

CTO NEXUS LATAM LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (2 filings)

Scientific and technological services; industrial analysis and research services

41
Education & Entertainment (2 filings)

Education; providing of training; entertainment; sporting and cultural activities

Frequently Asked Questions

How many trademarks does CTO NEXUS LATAM LLC have?

CTO NEXUS LATAM LLC has 4 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 pending, 2 abandoned.

What trademark classes does CTO NEXUS LATAM LLC file in?

CTO NEXUS LATAM LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 41 (Education & Entertainment). Class 42 covers scientific and technological services; industrial analysis and research services.

What are CTO NEXUS LATAM LLC's most well-known trademarks?

CTO NEXUS LATAM LLC's registered trademark portfolio includes well-known marks such as MYPAGE. These are among 1 currently registered trademark in the portfolio.

What is CTO NEXUS LATAM LLC's trademark registration success rate?

CTO NEXUS LATAM LLC has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 1 application is pending review.